Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Risky Business: Evolving Risks Across Workers’ Comp

A message from the Chief Executive Officer
Summer 2023

More than Skin-Deep: Untangling Topical Drug Classes and Costs

A breakdown of the diverse subcategories comprising dermatologicals prescribing and spend
Summer 2023

Unpredictable Costs: How Will Healthcare Price Inflation Impact Workers’ Comp?

Prices are rising for some healthcare products and services that will likely impact workers' compensation medical care
Summer 2023

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

WCRI Reports on the Pandemic’s Impact on Medical Utilization

Despite decreases in injury frequency across all groups, younger workers still saw higher use of emergency departments.
Mar 2025

Psilocybin and Ketamine Therapy Bills Introduced Across the Country

So far, seven psilocybin therapy bills have been introduced in 2025, with three ketamine therapy bills.
Mar 2025

Healthesystems Announces Key Promotion to Support Innovation in Data Analytics

Mike Theis has been promoted to AVP, Product Analytics and Business Strategy
Mar 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

WCRI Publishes Report on Off-Label Gabapentinoid Use

Less than 1% of gabapentin prescriptions were prescribed for an FDA-approved diagnosis.
Sep 2021

How Opioid Policy Impacts Opioid Utilization and Disability

A new WCRI report explores the impact recent opioid legislation has had on injured worker care.
Aug 2021

AMA Updates Impairment Rating Guidelines for the First Time Since 2008

Changes center around improving the assessment of mental and behavioral impairment.
Jul 2021
1 … 8 9 10 11 12 … 27

Whitepapers

lockmap-markermagnifiercrossmenucross-circle